Contemporary management of acute coronary syndrome (ACS) from diagnosis to therapy





Livestream organised & funded by AstraZeneca & Medtronic

  1. Identification and confirmation of ACS diagnosis
  2. Evidence basis for diagnostic pathway
  3. Pre-procedural work-up and pharmacological regime based on the latest clinical evidence base
  4. Invasive diagnostic work-up
  5. Assessment of stenosis severity
  6. Revascularisation
  7. Take Home Messages

This live case was also streamed at the AstraZeneca booth (E100 &E150) with Professor Carlo Di Mario as special guest moderator during the ESC 2015 at the Excel Centre, London, UK.  Learn more about iFR and FFR here.

The session is to inform physicians of:

  • Diagnosis and recognition of acute coronary syndromes as well as risk scoring and stratification
  • Understand the importance of an early invasive approach in reducing cardiac events and adverse outcomes
  • Understand the role of anti-platelets in the management of patient with acute coronary syndromes
  • Understand how to apply the evidence for anti platelets in clinical practice
  • Experience the invasive management of a patient with acute coronary syndrome, including gaining an appreciation of how revacularisation decisions are made, how stenoses are selected for treatment and how revascularisation is performed using state of the art equipment available in catheter labs globally

This case is aimed at cardiologists, interventional cardiologists and other healthcare professionals treating ACS patients.

The Resolute Onyx stent is approved for use on CE mark countries and not available for sale in the U.S.

August 2015 - ATLAS ID: 828.602,011 - Expiry date: August 2016